4-(2-bromoethyl)-3-methyl-4H-1,2,4-triazole hydrobromide, 95.0%, 1g

1-Benzyl-4-hydroxypiperidine, 97.0%, 500g

Recipiente de cristalización ROTILABO® con pico, 900 ml, 140 mm, 10 Unidad(es)

3-Chloroisoquinolin-1(2H)-one, 98%, 250mg

2-(2-Bromoethyl)-1,3-dioxane>97.0%(GC)5g

Aluminum trifluoromethanesulfonate, 99.0%, 25g

6-FLUOROIMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

1-[(2,4-difluorophenyl)methyl]-3-nitro-1H-pyrazole, 95.0%, 2g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-chlorophenyl)propanoic acid, 98%, 5g

tert-Butyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate, 95.0%, 1g

Methyl 2-methylnicotinate, 95.0%, 500g

2-(4-Methyl-1-piperazinyl)-4-pyrimidinamine, 95.0%, 1g

(3-Methoxybenzyl)triphenylphosphonium Chloride>98.0%(HPLC)(T)1g